Search

Your search keyword '"Scicali R"' showing total 150 results

Search Constraints

Start Over You searched for: Author "Scicali R" Remove constraint Author: "Scicali R"
150 results on '"Scicali R"'

Search Results

1. OC 10.4 Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors Reduce Platelet Nets Release Driver Thrombosis in Familial Hypercholesterolemia

2. Analysis of steatosis biomarkers and inflammatory profile after adding on PCSK9 inhibitor treatment in familial hypercholesterolemia subjects with nonalcoholic fatty liver disease

4. PCSK9 inhibitors have anti-inflammatory activity assessed by 1H-NMR glycoprotein profile in subjects at high or very high cardiovascular risk

6. The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group

7. Clinical Approach in the Management of Paediatric Patients with Familial Hypercholesterolemia: A National Survey Conducted by the LIPIGEN Paediatric Group

8. PCSK9 Inhibitors Have Apolipoprotein C-III-Related Anti-Inflammatory Activity, Assessed by 1H-NMR Glycoprotein Profile in Subjects at High or very High Cardiovascular Risk

9. Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real‐life setting: the PROSISA Study

12. Next generation sequencing in severe hypertrigliceridemia: Identification of a novel nonsense mutation of CREB3L3 gene

13. Inhibition of PCSK9 affects serum lipoprotein functions in patients with familial hypercholesterolemia

14. Cardiovascular risk management in type 2 diabetes mellitus: a joint position paper of the Italian Cardiology (SIC) and Italian Diabetes (SID) Societies

15. Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study

16. Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study

17. Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (Internal and Emergency Medicine, (2018), 13, 5, (651-660), 10.1007/s11739-018-1835-9)

20. Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study

21. Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study

22. Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (Internal and Emergency Medicine, (2018), 13, 5, (651-660), 10.1007/s11739-018-1835-9)

23. Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study

26. INFLAMMATION AND VENTRICULAR-VASCULAR COUPLING IN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME

27. Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity

28. Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome

29. Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study

30. Lipid and liver abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes

32. Detecting familial hypercholesterolemia by serum lipid profile screening in a hospital setting: Clinical, genetic and atherosclerotic burden profile

34. Ankle-Brachial Index and cardiovascular events in atrial fibrillation The ARAPACIS Study

37. Alpha- and beta-cell abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes

43. Cardiovascular risk management in type 2 diabetes mellitus: A joint position paper of the Italian Cardiology (SIC) and Italian Diabetes (SID) Societies

44. Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study

45. Analysis of gingival crevicular fluid biomarkers in patients with metabolic syndrome

46. Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity

47. Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN)

48. Atorvastatin but not pravastatin impairs mitochondrial function in human pancreatic islets and rat β-cells. Direct effect of oxidative stress

49. Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study

50. Apolipoprotein AI and HDL are reduced in stable cirrhotic patients with adrenal insufficiency: a possible role in glucocorticoid deficiency

Catalog

Books, media, physical & digital resources